Live Quote · AMEXAZTRHealthcare· Biotechnology

Azitra, Inc.

$0.15 9.30%($-0.02)
TickerSpark Score
49/100
Weak
100
Valuation
20
Profitability
10
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AZTR research report →

52-Week Range3% of range
Low
$0.10
Current
$0.15
High
$1.69
Company Overviewazitrainc.com

About the company

Azitra, Inc. is a pre-clinical biopharmaceutical company focused on developing precise treatments for various dermatological conditions. They innovate by utilizing engineered proteins and live biotherapeutic products to address skin diseases.

CEO
Francisco D. Salva
IPO
2023
Employees
12
HQ
Branford, CT, US

Price Chart

-91.06% · this period
$1.69$0.91$0.14Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.62M
P/E
-0.20
P/S
0.00
P/B
0.22
EV/EBITDA
0.74
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-251.51%
ROIC
-109.02%
Growth & Income
Revenue
$0 · -100.00%
Net Income
$-10,955,370 · -22.17%
EPS
$-2.25 · -532.28%
Op Income
$-10,966,665
FCF YoY
-8.02%
Performance & Tape
52W High
$1.69
52W Low
$0.10
50D MA
$0.21
200D MA
$0.33
Beta
-1.21
Avg Volume
11.43M

Get TickerSpark's AI analysis on AZTR

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 16, 26Salva Francisco D.other4,064,050
Jun 16, 26Salva Francisco D.other500
Apr 20, 26Staskey Normother35,524
Apr 20, 26Salva Francisco D.other220,879
Apr 20, 26Whitfill Travisother64,300
Mar 18, 26Salva Francisco D.buy4,064,050
Mar 18, 26Salva Francisco D.buy4,064,050
Mar 18, 26Salva Francisco D.buy500
Dec 19, 25Whitfill Travisother23,724
Dec 19, 25Salva Francisco D.other59,309
Coverage · AZTR

Our AZTR coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on AZTR yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate AZTR report →
Internal Compare

Similar companies

Peers in the same neighborhood.